Trial intelligence / Profile preview

Phase 3 randomized double-blind study of lidocaine + prilocaine cutaneous spray for adult men with lifelong premature ejaculation

CTR20253156Phase 3Active

Sponsor
Jiangsu Runbang Pharmaceutical
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lidocaine, prilocaine in premature ejaculation (PE), sponsored by Jiangsu Runbang Pharmaceutical. Started Dec 2025; status: active.

02

Drugs

lidocaineprilocaine
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on CTR20253156.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20253156.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call